Celltrion stock
Scope
Date
~
-
Private equity
EQT sells Shinhan Financial stake in block deal at 30% IRR
EQT Private Capital Asia sold 415.5 billion won ($311.9 million) worth of shares in South Korea’s Shinhan Financial Group Co. in a block deal ...
Mar 07, 2024 (Gmt+09:00)
-
Korean stock market
NPS to invest up to $8.2 bn in undervalued Korean stocks
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, is expected to invest up to 11 trillion won ($8.2 ...
Mar 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion ships initial supply of Zymfentra to US
South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...
Feb 29, 2024 (Gmt+09:00)
-
Pension funds
NPS logs record return rate in 2023 on stocks’ bull run
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, posted a 13.59% annualized return last year, makin...
Feb 28, 2024 (Gmt+09:00)
-
The KED View
Defy convention with long-run plans to upvalue Korean stocks
The South Korean stock market has been on an upward swing in recent weeks, with many partly attributing it to President Yoon Suk Yeol’s pledge...
Feb 23, 2024 (Gmt+09:00)
-
Asset management
India equity funds top overseas stock funds in S.Korea
India equity funds registered in South Korea have doubled their investors' wealth over the past five years, luring high-net-worth individuals lookin...
Feb 19, 2024 (Gmt+09:00)
-
Korean stock market
Foreign investors net buyers of Korean stocks for 3rd straight month
Foreign investors bought more South Korean stocks and bonds in January, extending their buying spree to three months.The Financial Supervisory Servi...
Feb 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to deliver three treatments to Peru
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...
Feb 15, 2024 (Gmt+09:00)
-
Earnings
Korea’s GS offers dim outlook after weak earnings; stocks down
GS Holdings Corp., the holding company of South Korea’s energy-to-retail conglomerate GS Group, on Wednesday provided a dismal business outloo...
Feb 14, 2024 (Gmt+09:00)
-
Short selling
Korean stock market volatility up since short-selling ban
The South Korean stock market has seen increased volatility and few rallies over the past three months, in sharp contrast to government hopes that i...
Feb 13, 2024 (Gmt+09:00)
-
Korean stock market
Hyundai Department stocks down on cheap dividend policy
Hyundai Department Store Group, a South Korean major retail conglomerate, has unveiled the group companies’ dividend payout plans for the mid ...
Feb 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima SC, Yuflyma to Norway
South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...
Feb 07, 2024 (Gmt+09:00)
-
Sovereign bonds
KIC posts 11.6% return for 2023 amid tech stock boom
Sovereign wealth fund Korea Investment Corporation (KIC) posted an 11.6% return for last year, driven by strong gains on listed stocks. The state-ru...
Feb 05, 2024 (Gmt+09:00)
-
Earnings
Naver logs record earnings on e-commerce, content; stocks up
South Korea’s online giant Naver Corp. reported record earnings on strong performances of its e-commerce and content businesses, sending its s...
Feb 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Korean stock market
Global X to liquidate China-exposed ETFs on poor returns
Global X ETFs, the New York-based provider of exchange-traded funds, will liquidate 19 ETFs, including 11 China-exposed funds, next month to stop th...
Jan 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
Jan 18, 2024 (Gmt+09:00)
-
Pension funds
NPS picks tech, electronics as its favorite local stocks in 2023
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, picked information tech, electric and electronic s...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion Holdings eyes Nasdaq IPO by early 2025: chairman
South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...
Jan 16, 2024 (Gmt+09:00)
-
Pension funds
NPS bets on Samsung Electro-Mechanics, sells POSCO stocks in Q4
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, saw the amount of listed local shares it owns rise...
Jan 15, 2024 (Gmt+09:00)
-
Korean startups
Korea’s unicorn startups fly high as IPO plans revived
South Korea’s unicorn startups, or venture firms with a corporate value of at least 1 trillion won ($760 million), are poised to return to the...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion revises up earnings goals to overtake Amgen
Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Business & Politics
South Korea set to abolish financial investment gains tax: Yoon
South Korea plans to abolish capital gains taxes on financial investments to revitalize the lackluster domestic financial market and help individual...
Jan 02, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
-
Electronics
LG Display plans $1 bn rights offering for smaller OLED biz
LG Display Co., the world’s top manufacturer of large-size organic light-emitting diode (OLED) panels, said on Monday it plans to raise 1.36 t...
Dec 18, 2023 (Gmt+09:00)
-
Leadership & Management
MBK raises Hankook bid price, asks FSS to probe Cho's stock purchase
The sibling rivalry for control of Hankook & Company Co., the holding firm of South Korea’s largest tire maker Hankook Tire & Techno...
Dec 15, 2023 (Gmt+09:00)
-
IPOs
LS Materials’ share price quadruples on Kosdaq debut
The share price of LS Materials Co., a South Korean energy storage device maker, quadrupled on its Kosdaq market debut Wednesday given its rosy earn...
Dec 12, 2023 (Gmt+09:00)